Literature DB >> 35638924

Relation of MRI Aortic Wall Area and Plaque to Incident Cardiovascular Events: The Framingham Heart Study.

Ulf Neisius1, Philimon N Gona1, Noriko Oyama-Manabe1, Michael L Chuang1, Christopher J O'Donnell1, Warren J Manning1, Connie W Tsao1.   

Abstract

Background Arterial arteriosclerosis and atherosclerosis reflect vascular disease, the subclinical detection of which allows opportunity for cardiovascular disease (CVD) prevention. Larger cohort studies simultaneously quantifying anatomic thoracic and abdominal aortic pathologic abnormalities are lacking in the literature. Purpose To investigate the association of aortic wall area (AWA) and atherosclerotic plaque presence and burden as measured on MRI scans with incident CVD in a community sample. Materials and Methods In this prospective cohort study, participants in the Framingham Heart Study Offspring Cohort without prevalent CVD underwent 1.5-T MRI (between 2002-2005) of the descending thoracic and abdominal aorta with electrocardiogram-gated axial T2-weighted black-blood acquisitions. The wall thickness of the thoracic aorta was measured at the pulmonary bifurcation level and used to calculate the AWA as the difference between cross-sectional vessel area and lumen area. For primary or secondary analyses, multivariable Cox proportional hazards regression models were used to examine the association of aortic MRI measures with risk of first-incident CVD events or stroke and coronary heart disease, respectively. Results In 1513 study participants (mean age, 64 years ± 9 [SD]; 842 women [56%]), 223 CVD events occurred during follow-up (median, 13.1 years), of which 97 were major events (myocardial infarction, ischemic stroke, or CVD death). In multivariable analysis, thoracic AWA and prevalent thoracic plaque were associated with incident CVD (hazard ratio [HR], 1.20 per SD unit [95% CI: 1.05, 1.37] [P = .006] and HR, 1.63 [95% CI: 1.12, 2.35] [P = .01], respectively). AWA and prevalent thoracic plaque were associated with increased hazards: 1.32 (95% CI: 1.07, 1.62; P = .01) and 2.20 (95% CI: 1.28, 3.79; P = .005), for stroke and coronary heart disease, respectively. Conclusion In middle-aged community-dwelling adults, thoracic aortic wall area (AWA), plaque prevalence, and plaque volumes measured with MRI were independently associated with incident cardiovascular disease, with AWA associated in particular with stroke, and plaque associated with coronary heart disease. Clinical trial registration no. NCT00041418 © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Peshock in this issue.

Entities:  

Mesh:

Year:  2022        PMID: 35638924      PMCID: PMC9434818          DOI: 10.1148/radiol.210830

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  24 in total

1.  Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Ashkan A Malayeri; Shunsuke Natori; Hossein Bahrami; Alain G Bertoni; Richard Kronmal; João A C Lima; David A Bluemke
Journal:  Am J Cardiol       Date:  2008-05-24       Impact factor: 2.778

Review 2.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

3.  Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study.

Authors:  Farouc A Jaffer; Christopher J O'Donnell; Martin G Larson; Stephen K Chan; Kraig V Kissinger; Michelle J Kupka; Carol Salton; Rene M Botnar; Daniel Levy; Warren J Manning
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

4.  Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation.

Authors:  Mieczyslaw Litwin; Elke Wühl; Claudia Jourdan; Justyna Trelewicz; Anna Niemirska; Kathrin Fahr; Katarzyna Jobs; Ryszard Grenda; Zbigniew T Wawer; Pawel Rajszys; Jörgen Tröger; Otto Mehls; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2005-03-16       Impact factor: 10.121

5.  Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden.

Authors:  S K Chan; F A Jaffer; R M Botnar; K V Kissinger; L Goepfert; M L Chuang; C J O'Donnell; D Levy; W J Manning
Journal:  J Cardiovasc Magn Reson       Date:  2001       Impact factor: 5.364

6.  Determinants and normal values of ascending aortic diameter by age, gender, and race/ethnicity in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Evrim B Turkbey; Aditya Jain; Craig Johnson; Alban Redheuil; Andrew E Arai; Antoinette S Gomes; James Carr; W Gregory Hundley; Gisela Teixido-Tura; John Eng; João A C Lima; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2013-05-16       Impact factor: 4.813

7.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

8.  Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas heart study.

Authors:  Christopher D Maroules; Eric Rosero; Colby Ayers; Ronald M Peshock; Amit Khera
Journal:  Radiology       Date:  2013-06-18       Impact factor: 11.105

Review 9.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

10.  Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study.

Authors:  Udo Hoffmann; Joseph M Massaro; Ralph B D'Agostino; Sekar Kathiresan; Caroline S Fox; Christopher J O'Donnell
Journal:  J Am Heart Assoc       Date:  2016-02-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.